Jane Street’s Imperva, Inc. IMPV Stock Holding History

Jane Street’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,415	Closed	-$259K	–	5339
2017 Q2	$259K	Sell	5,415 -42	-0.8%	-$1.96K	﹤0.01%	3755
2017 Q1	$224K	Buy	+5,457	New	+$228K	﹤0.01%	3750
2015 Q3	–	Sell	-35,139	Closed	-$2.33M	–	4420
2015 Q2	$2.38M	Buy	+35,139	New	+$1.94M	0.02%	878
2014 Q3	–	Sell	-29,219	Closed	-$765K	–	3318
2014 Q2	$765K	Buy	+29,219	New	+$754K	0.01%	1089

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Jane Street's IMPV Position: Q3 2017 in Review

Jane Street sold out of Imperva, Inc. (IMPV) in Q3 2017, closing a stake of 5,415 shares — an estimated $259K sold.

Jane Street first reported a position in IMPV in Q2 2014 and held it in 4 quarters. The position peaked at $2.38M in Q2 2015. 171 funds tracked by Wall St. Rank hold IMPV as of Q3 2017.

Jane Street reported no remaining Imperva, Inc. position as of Q3 2017 after selling out during the quarter.
Jane Street sold 5,415 Imperva, Inc. shares in Q3 2017, an estimated $259K.
Jane Street first reported a position in Imperva, Inc. in Q2 2014 and held it in 4 quarters.
Jane Street's Imperva, Inc. position peaked at $2.38M in Q2 2015.
171 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2017.

Based on Jane Street's 13F filing for Q3 2017, filed 14 Nov 2017.